Valor pronóstico de las isoenzimas de LDH en pacientes con linforma no hodgkin

Zabner de Oziel, Priva; Somoza, Rosa; Wallis, Valentina; Galicia, Claudia; Desenne, Jean; Monzón de Orosco, Ana; González, Marina; Acquatella, Gretta; Morales, Marisela; Ordoñez, Yasmín; Torres, María Alejandra; Natale, Antonieta; Muller, Aixa.
Acta cient. Soc. Venez. Bioanalistas Esp ; 16(1): 6-21, 2013. tab, graf
Artículo en Español | LILACS | ID: lil-733455

Documentos relacionados

  1. Evaluation of the clinical characteristics and prognostic factors of gastrointestinal non-Hodgkin lymphoma based on anatomical sites and histological subtype.
  2. [Expression and significance of jumonji domain-containing protein 2B and hypoxia inducible factor-1α in non-Hodgkin lymphoma tissues in children].
  3. A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study.
  4. The forgotten survivor: A comprehensive review on Non-Hodgkin lymphoma survivorship.
  5. Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literature.
  6. Malnutrition diagnosed by GLIM criteria better predicts long-term outcomes for patients with non-Hodgkin's lymphoma: A prospective multicenter cohort study.
  7. Elraglusib (formerly 9-ING-41) possesses potent anti-lymphoma properties which cannot be attributed to GSK3 inhibition.
  8. [Clinical analysis of 7 cases of pregnancy with non-Hodgkin lymphoma].
  9. Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol.
  10. A case of non-Hodgkin lymphoma of the upper gingiva with minimal residual disease detected in cryopreserved ovarian tissue: A case report.